Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase 1 open-label, multiple ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies.
PaperCitations, authors & open-access status
Phase 1 open-label, multiple ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1 citations, 2017 year and closed oa status.
1
Citations
2017
Year
closed
OA Status